[Pseudomyxoma Peritonei: New Concept and New Therapeutic Approach]
Overview
Affiliations
Pseudomyxoma peritonei is a rare disease, usually diagnosed after the discover of "jelly belly" by laparotomy. With the progress of immunohistochemistry, most authors now acknowledge the appendix to be the principal origin of this disease. Pseudomyxoma peritonei need to considered as border line malignant disease because of its inevitable persistence and progression without adapted therapeutic approach: cytoreductive surgery combined with perioperative intraperitoneal chemotherapy (intraperitoneal chemohyperthermia and/or immediate postoperative intraperitoneal chemotherapy) into specialized centres. The principal prognostic factors are the prior surgical history, the completeness of cytoreduction and especially the histopathologic grade.
[Pseudomyxoma peritonei (PMP) secondary to mucinous carcinoma of the ovary: a case study].
Belhamidi M, Zorkani Y, Krimou H, Kaoukabi A, Menfaa M, Sakit F Pan Afr Med J. 2019; 33:283.
PMID: 31692896 PMC: 6815498. DOI: 10.11604/pamj.2019.33.283.17203.
Montori G, Coccolini F, Fugazzola P, Ceresoli M, Tomasoni M, Rubicondo C J Gastrointest Oncol. 2018; 9(2):241-253.
PMID: 29755762 PMC: 5934148. DOI: 10.21037/jgo.2017.12.04.
A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei.
Gilbreath J, Semino-Mora C, Friedline C, Liu H, Bodi K, McAvoy T Orphanet J Rare Dis. 2013; 8:105.
PMID: 23844722 PMC: 3729368. DOI: 10.1186/1750-1172-8-105.
Semino-Mora C, Liu H, McAvoy T, Nieroda C, Studeman K, Sardi A Ann Surg Oncol. 2008; 15(5):1414-23.
PMID: 18299935 PMC: 2570966. DOI: 10.1245/s10434-007-9778-9.
Appendiceal mucocoeles and pseudomyxoma peritonei.
Dixit A, Robertson J, Mudan S, Akle C World J Gastroenterol. 2007; 13(16):2381-4.
PMID: 17511043 PMC: 4147153. DOI: 10.3748/wjg.v13.i16.2381.